CLINICAL_TRIALS
trial_result
· 2021-01-28
Clinical Trial Update: A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease [Phase 2]
Summary
Phase 2 trial update on 6R-BH4 for sickle cell disease; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioMarin Pharmaceutical | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28